2023 Q3 Form 10-Q Financial Statement

#000121390023065046 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $4.508M $3.551M $2.157M
YoY Change 128.14% 64.63% 69.98%
Cost Of Revenue $661.0K $585.0K $358.0K
YoY Change 156.2% 63.41% -4.28%
Gross Profit $3.847M $2.966M $1.799M
YoY Change 123.92% 64.87% 101.01%
Gross Profit Margin 85.34% 83.53% 83.4%
Selling, General & Admin $6.724M $6.799M $6.278M
YoY Change 18.86% 8.3% 19.08%
% of Gross Profit 174.79% 229.23% 348.97%
Research & Development $1.249M $1.155M $1.341M
YoY Change -22.76% -13.87% 62.55%
% of Gross Profit 32.47% 38.94% 74.54%
Depreciation & Amortization $300.0K $322.0K $141.0K
YoY Change 96.08% 128.37% 54.37%
% of Gross Profit 7.8% 10.86% 7.84%
Operating Expenses $7.973M $7.954M $7.619M
YoY Change 9.61% 4.4% 24.96%
Operating Profit -$4.126M -$4.988M -$5.820M
YoY Change -25.74% -14.3% 11.88%
Interest Expense $90.00K $2.250K $38.00K
YoY Change -12.62% -94.08% 2892.13%
% of Operating Profit
Other Income/Expense, Net $94.00K $85.00K $38.00K
YoY Change -8.74% 123.68% -97.33%
Pretax Income -$4.032M -$4.903M -$5.782M
YoY Change -26.06% -15.2% 53.0%
Income Tax -$445.0K
% Of Pretax Income
Net Earnings -$4.032M -$4.903M -$5.337M
YoY Change -26.06% -8.13% 84.42%
Net Earnings / Revenue -89.44% -138.07% -247.43%
Basic Earnings Per Share -$0.68 -$1.03 -$0.08
Diluted Earnings Per Share -$0.68 -$1.03 -$75.36K
COMMON SHARES
Basic Shares Outstanding 5.985M shares 4.749M shares 70.82K shares
Diluted Shares Outstanding 5.945M shares 4.751M shares 4.448M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.50M $8.442M $26.33M
YoY Change -37.63% -67.94% 10.97%
Cash & Equivalents $13.46M $8.442M $26.33M
Short-Term Investments
Other Short-Term Assets $1.300M $356.0K $480.0K
YoY Change -1.89% -25.83% 103.64%
Inventory $2.495M $2.368M $1.739M
Prepaid Expenses
Receivables $589.0K $238.0K $575.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.84M $11.40M $29.12M
YoY Change -29.51% -60.84% 14.62%
LONG-TERM ASSETS
Property, Plant & Equipment $178.0K $114.0K $99.00K
YoY Change 131.17% 15.15% -49.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $760.0K $819.0K $761.0K
YoY Change -10.9% 7.62% 10.95%
Total Long-Term Assets $2.269M $2.818M $4.357M
YoY Change -45.76% -35.32% -26.0%
TOTAL ASSETS
Total Short-Term Assets $17.84M $11.40M $29.12M
Total Long-Term Assets $2.269M $2.818M $4.357M
Total Assets $20.11M $14.22M $33.48M
YoY Change -31.82% -57.52% 6.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.033M $2.284M $2.053M
YoY Change 59.55% 11.25% -10.69%
Accrued Expenses $5.390M $4.210M $3.523M
YoY Change 15.42% 19.5% 20.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.508M $6.575M $5.644M
YoY Change 28.09% 16.5% -1.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $600.0K $583.0K $664.0K
YoY Change -6.98% -12.2% -28.07%
Total Long-Term Liabilities $600.0K $583.0K $664.0K
YoY Change -6.98% -12.2% -28.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.508M $6.575M $5.644M
Total Long-Term Liabilities $600.0K $583.0K $664.0K
Total Liabilities $9.068M $7.158M $6.308M
YoY Change 24.44% 13.47% -5.58%
SHAREHOLDERS EQUITY
Retained Earnings -$161.2M -$157.1M -$135.1M
YoY Change 14.65% 16.29% 17.23%
Common Stock $172.3M $164.3M $162.3M
YoY Change 5.79% 1.22% 333235.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.04M $7.064M $27.17M
YoY Change
Total Liabilities & Shareholders Equity $20.11M $14.22M $33.48M
YoY Change -31.82% -57.52% 6.98%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$4.032M -$4.903M -$5.337M
YoY Change -26.06% -8.13% 84.42%
Depreciation, Depletion And Amortization $300.0K $322.0K $141.0K
YoY Change 96.08% 128.37% 54.37%
Cash From Operating Activities -$2.380M -$3.312M -$3.244M
YoY Change -48.34% 2.1% 94.71%
INVESTING ACTIVITIES
Capital Expenditures $80.00K $91.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$80.00K -$91.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.490M 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.380M -3.312M -3.244M
Cash From Investing Activities -80.00K -91.00K 0.000
Cash From Financing Activities 7.490M 0.000 0.000
Net Change In Cash 5.030M -3.403M -3.244M
YoY Change -209.18% 4.9% -157.6%
FREE CASH FLOW
Cash From Operating Activities -$2.380M -$3.312M -$3.244M
Capital Expenditures $80.00K $91.00K
Free Cash Flow -$2.460M -$3.403M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4903000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
625000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001560258
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38538
dei Entity Registrant Name
EntityRegistrantName
electroCore, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3454976
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Forge Way
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 205
dei Entity Address City Or Town
EntityAddressCityOrTown
Rockaway
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07866
dei City Area Code
CityAreaCode
(973)
dei Local Phone Number
LocalPhoneNumber
290-0097
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
ECOR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5985043 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8442000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17712000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
250000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
250000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
238000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
401000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
2368000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1982000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
106000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
828000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
11404000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
21173000 usd
CY2023Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
1351000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2194000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
114000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
534000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
565000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
819000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
774000 usd
CY2023Q2 us-gaap Assets
Assets
14222000 usd
CY2022Q4 us-gaap Assets
Assets
24756000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2284000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2129000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4210000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4842000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
81000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
74000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6575000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7045000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
583000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
625000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
7158000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
7670000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000 shares
CY2023Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
10000000 shares
CY2023Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2023Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
71173 shares
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
71173 shares
CY2022Q4 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
0.001
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4752475 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4752475 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4744886 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4744886 shares
CY2023Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
5000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
5000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164275000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
163520000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-157140000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146370000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-76000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-69000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7064000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17086000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14222000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24756000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3551000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2157000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6331000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4056000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
585000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
358000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1043000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
718000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2966000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
1799000 usd
us-gaap Gross Profit
GrossProfit
5288000 usd
us-gaap Gross Profit
GrossProfit
3338000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1155000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1341000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2964000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2275000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6799000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6278000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13509000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12464000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
7954000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
7619000 usd
us-gaap Operating Expenses
OperatingExpenses
16473000 usd
us-gaap Operating Expenses
OperatingExpenses
14739000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4988000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5820000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11185000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11401000 usd
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
85000 usd
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
38000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
204000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
42000 usd
CY2023Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
CY2022Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
85000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
38000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
204000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
37000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5782000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10981000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11364000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-445000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-211000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-445000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4903000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5337000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10770000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10919000 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.2
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.25
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4751000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4751000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4448000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4448000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4747000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4747000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4853000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4853000 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4903000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5337000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10770000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10919000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-63000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-58000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-7000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-85000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-63000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-58000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-85000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4966000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5395000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10777000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11004000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
17086000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5867000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
572000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4903000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-63000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
183000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7064000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
36582000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5582000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
777000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
31750000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5337000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-58000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
752000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
27107000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10770000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10919000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
755000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1529000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
444000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
247000 usd
ecor Net Noncash Lease Expense
NetNoncashLeaseExpense
30000 usd
ecor Net Noncash Lease Expense
NetNoncashLeaseExpense
21000 usd
us-gaap Inventory Write Down
InventoryWriteDown
65000 usd
us-gaap Inventory Write Down
InventoryWriteDown
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
28000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-135000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
137000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
71000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-289000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-723000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-823000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
155000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1115000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-631000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-963000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-35000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-29000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9172000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8024000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
91000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-91000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-7000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-85000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9270000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8109000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17962000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34689000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8692000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26580000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
211000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
445000 usd
us-gaap Interest Paid Net
InterestPaidNet
4000 usd
us-gaap Interest Paid Net
InterestPaidNet
4000 usd
CY2023Q2 ecor Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
2 subsidiary
CY2023Q1 us-gaap Debt Instrument Convertible Stock Price Trigger
DebtInstrumentConvertibleStockPriceTrigger
1
CY2023Q1 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
10
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-15
us-gaap Use Of Estimates
UseOfEstimates
<div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div id="t_ft_Q9Y8OSSSWG00000000000000000000b"> <table cellpadding="0" cellspacing="0" style="height: 10px; border-collapse: collapse; margin-left: 0px; font-family: 'times new roman'; font-size: 10pt; width: 100%;" width="100%"> <tbody> <tr style="height: 10px;"> <td style="vertical-align: top; height: 10px; width: 3%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;"> (c) </span></p> </td> <td style="vertical-align: top; height: 10px; width: 97%;"> <p style="margin: 0pt 0pt 0pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;"> Use of Estimates </span></p> </td> </tr> </tbody> </table> </div> </div> <p style="margin: 10pt 0pt 0pt; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2; text-align: justify; text-indent: 0pt;"><span style="font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit; margin: 6pt 0in 0in; text-align: justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include allowances for doubtful accounts, trade credits, rebates, co-payment assistance and sales returns, valuation of inventory, estimated useful life of licensed products and cloud computing arrangements, stock compensation, incremental borrowing rate and contingencies.   </span></span></p> </div> </div> </div>
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8442000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26330000 usd
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
250000 usd
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
250000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
8692000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
26580000 usd
CY2023Q2 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
0 usd
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="margin: 0pt; text-indent: 0pt;"> <table style="width: 100%; margin-left: 0.1px; border-collapse: collapse; font-family: 'times new roman'; font-size: 10pt;"> <tbody> <tr> <td style="width: 3%;"><span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: bold; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">(g)</span></td> <td style="width: 97%;"><span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: bold; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">Prior Year Presentation</span></td> </tr> </tbody> </table> </div> <p style="margin: 10pt 0pt 0pt; color: #000000; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0pt; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; font-family: 'Times New Roman', serif; line-height: 1.2; text-align: justify;"><span style="font-size: 10pt; line-height: inherit;"><span style="line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="font-family: 'Times New Roman', serif; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;"> </span></span></span><span style="line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="font-family: 'Times New Roman', serif; color: black; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; line-height: inherit;">Prior year presentation has been conformed to current year presentation.</span></span></span></span></p>
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.598 pure
ecor Federal Supply Schedule Expire Date
FederalSupplyScheduleExpireDate
2024-01-15
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3551000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2157000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4056000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3551000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2157000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6331000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4056000 usd
ecor Payment Term For Customers
PaymentTermForCustomers
P30D
CY2023Q2 ecor Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
1334000 usd
CY2022Q4 ecor Inventory Raw Materials Current And Noncurrent
InventoryRawMaterialsCurrentAndNoncurrent
944000 usd
CY2023Q2 ecor Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
2194000 usd
CY2022Q4 ecor Inventory Work In Process Current And Noncurrent
InventoryWorkInProcessCurrentAndNoncurrent
2879000 usd
CY2023Q2 ecor Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
191000 usd
CY2022Q4 ecor Inventory Finished Goods Current And Noncurrent
InventoryFinishedGoodsCurrentAndNoncurrent
353000 usd
CY2023Q2 ecor Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
3719000 usd
CY2022Q4 ecor Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
4176000 usd
CY2023Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
1351000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
2194000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
2368000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1982000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
300000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
700000 usd
CY2023Q2 ecor Inventory Noncurrent Raw Materials
InventoryNoncurrentRawMaterials
600000 usd
CY2022Q4 ecor Inventory Noncurrent Raw Materials
InventoryNoncurrentRawMaterials
100000 usd
CY2023Q2 ecor Inventory Noncurrent Work In Process
InventoryNoncurrentWorkInProcess
800000 usd
CY2022Q4 ecor Inventory Noncurrent Work In Process
InventoryNoncurrentWorkInProcess
2100000 usd
CY2023Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
38000 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
76000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
534000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
565000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
81000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
74000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
583000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
664000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
699000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M6D
CY2023Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.138 pure
CY2022Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.138 pure
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
82000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
168000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
171000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
161000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
157000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
216000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
955000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
291000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
664000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
483000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
524000 usd
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1436000 usd
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2042000 usd
CY2023Q2 ecor Accrued Legal Fees Litigation Expense Current
AccruedLegalFeesLitigationExpenseCurrent
1035000 usd
CY2022Q4 ecor Accrued Legal Fees Litigation Expense Current
AccruedLegalFeesLitigationExpenseCurrent
1001000 usd
CY2023Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
24000 usd
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
264000 usd
CY2023Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
739000 usd
CY2022Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
534000 usd
CY2023Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
207000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
usd
CY2023Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
180000 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
133000 usd
CY2023Q2 us-gaap Deferred Income Current
DeferredIncomeCurrent
36000 usd
CY2022Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
152000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
70000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
192000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4210000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4842000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
2250 usd
us-gaap Interest Expense
InterestExpense
3867 usd
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-15
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
479000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
492000 shares
CY2023Q1 us-gaap Proceeds From Operating Activities
ProceedsFromOperatingActivities
211000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
440000 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
108000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
335000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
58.79
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
76.92
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y7M6D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
183000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
752000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
755000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1529000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1300000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y2M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.50 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.95
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.14 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.039 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2020Q3 ecor Number Of Investors As Defendants
NumberOfInvestorsAsDefendants
2 investors

Files In Submission

Name View Source Status
0001213900-23-065046-index-headers.html Edgar Link pending
0001213900-23-065046-index.html Edgar Link pending
0001213900-23-065046.txt Edgar Link pending
0001213900-23-065046-xbrl.zip Edgar Link pending
ecor-20230630.htm Edgar Link pending
ecor-20230630.xsd Edgar Link pending
ex311_1.htm Edgar Link pending
ex312_2.htm Edgar Link pending
ex321_3.htm Edgar Link pending
ex322_4.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
ecor-20230630_def.xml Edgar Link unprocessable
ecor-20230630_lab.xml Edgar Link unprocessable
ecor-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ecor-20230630_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ecor-20230630_cal.xml Edgar Link unprocessable